The new asthma injection helped many patients stop steroids and reduce attacks.
A new treatment for severe asthma has gained attention after showing steady progress in a large group of patients over a one-year period. This treatment uses a drug called tazepilumab, which is given by monthly injection. The study followed people who had long struggled with breathing problems and often depended on daily steroid pills. These tablets are common in asthma care but can bring many unwanted health problems when taken for long stretches. Because of this, doctors are trying to find safer methods that still keep symptoms under control. The new findings are suggesting that some patients may finally have another option.
The study involved people from several countries and tracked how their bodies responded to stable doses of the injection over the course of a year. Many participants had flare-ups over the years that were difficult to manage. He had often tried different combinations of medications and still dealt with sudden attacks that interfered with daily life. The study group showed a change immediately after the first dose. Some people noticed changes within two weeks, noting better breathing and fewer interruptions during normal activities, such as walking, climbing stairs, or talking for long periods of time.
The researchers reported that more than half of the group could completely stop using daily steroid pills without experiencing an increase in breathing problems. This is important because long-term steroid use can cause problems with blood sugar, bone strength, weight changes, and make you more prone to infections. Many people with very severe forms of asthma remain on these pills because their symptoms are not well controlled. The new treatment could offer a different path for some of them, providing relief without a daily pill that carries so many risks.
Another important point of the study was the number of people who avoided asthma attacks altogether. Two-thirds of this group completed the year without an attack. For many, this kind of stability was previously out of reach. Doctors also measured lung function and general well-being, and scores increased throughout the study. People reported having an easier time breathing fuller, sleeping through the night, and staying active during the day.
Tezepelumab is part of a new group of medicines called biologics. These drugs are designed to target certain patterns in the body rather than affecting many areas at once the way steroids do. By calming the areas that trigger inflammation in the lungs, the drug helps keep the airways open. Doctors participating in the study believe the findings indicate a steady move toward treatments that make managing asthma less risky over the long term.
More than three hundred patients from dozens of centers were included in this study. Doctors say the results show how steady, targeted care can help those who have struggled the most. Although no one treatment works for everyone, this one-year study shows that some long-standing problems can be reversed when the right methods are used.
Sources:
Advances in asthma care: Monthly injections help patients take daily steroids
A monthly jab can replace a daily steroid pill for people with asthma
